Cancer Therapy Advisor offers the latest cancer management and treatment info, cancer research news, and more for oncologists and medical professionals.
Translational Lung Cancer Research provides practical up-to-date information on prevention, early detection, diagnosis, and treatment of lung cancer.
Texas Oncology is a leader in ground–breaking cancer research and clinical trials in Texas, paving the way for new breakthroughs in cancer care. If you are a Texas Oncology patient, you may be able to take part in these innovative clinical trials, including: Prevention trials focus on ...
The researchers validated this therapy in various animal models, and the results showed that this synthetically bioengineered bacteria significantly inhibits the growth, recurrence, and metastasis of multiple types of tumors. Currently,...
The results of the NIAGARA trial have considerably advanced treatment for patients with muscle-invasive bladder cancer, establishing a new therapeutic standard for cisplatin-eligible patients. Future trials will help to answer remaining questions about perioperative treatment optimization. ...
Historically, the primary focus of cancer research has been molecular and clinical studies of a few essential pathways and genes. Recent years have seen the rapid accumulation of large-scale cancer omics data catalysed by breakthroughs in high-throughput technologies. This fast data growth has given...
According to data from Cancer Research UK, there are about 48,500 cases of lung cancer every year in the UK, 72% of which are caused by smoking. Image:Smoking causes 72% of all lung cancers, according to Cancer Research UK. File pic ...
Clinical trials are a vital part of the process in finding new cancer treatments and ultimately a cure for cancer. Without these research studies, many of the advances we see today in cancer detection, treatment and prevention would never have happened. ...
Cancer Research UK Launches National Childhood Cancer Trials Teamdoi:10.1097/01.COT.0000373741.68489.e9NAOncology Times
The TRACERx study (https://clinicaltrials.gov/ct2/show/NCT01888601) is a prospective observational cohort study that aims to transform our understanding of NSCLC, the design of which has been approved by an independent research ethics committee (13/LO/1546). Informed consent for entry into the...